CLINICAL_TRIALS
ClinicalTrials.gov record update
Phase 1b Open-label, Long-term Extension Basket Trial of RAY121 to Inhibit Classical Complement Pathway in Immunological Diseases (RAINBOW-LTE Trial)
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT06723106
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:28:04.277221+00:00
- Published At
- 2026-04-02T00:00:00+00:00
- Record Updated At
- 2026-04-02
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Antiphospholipid Syndrome (APS)", "Bullous Pemphigoid (BP)", "Beh\u00e7et\u0027s Syndrome (BS)", "Dermatomyositis (DM)", "Immune-mediated Necrotizing Myopathy (IMNM)", "Immune Thrombocytopenia (ITP)"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-04-02"- protocolSection.identificationModule.nctId
"NCT06723106"- protocolSection.identificationModule.officialTitle
"Phase 1b Open-label, Long-term Extension Basket Trial of RAY121 to Inhibit Classical Complement Pathway in Immunological Diseases (RAINBOW-LTE Trial)"- protocolSection.statusModule.overallStatus
"ENROLLING_BY_INVITATION"- protocolSection.designModule.phases
["PHASE1"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.